Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Larson

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Chest|March 15, 2005
A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic riskBradley J G Larson, Marc S Zumberg, Craig S Kitchens
Integrative Organismal Biology (Oxford, England)|April 1, 2021
A Quantitative Analysis of <i>Micrurus</i> Coral Snakes Reveals Unexpected Variation in Stereotyped Anti-Predator Displays Within a Mimicry SystemT Y Moore, S M Danforth, J G Larson, et al.
American Journal of Clinical Oncology|April 2, 2005
A phase II study of gemcitabine in patients with relapsed or refractory low-grade non-Hodgkin lymphomaBradley J G Larson, John M Waples, Annette Pusateri, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Chest|March 15, 2005
A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic riskBradley J G Larson, Marc S Zumberg, Craig S Kitchens
Integrative Organismal Biology (Oxford, England)|April 1, 2021
A Quantitative Analysis of <i>Micrurus</i> Coral Snakes Reveals Unexpected Variation in Stereotyped Anti-Predator Displays Within a Mimicry SystemT Y Moore, S M Danforth, J G Larson, et al.
American Journal of Clinical Oncology|April 2, 2005
A phase II study of gemcitabine in patients with relapsed or refractory low-grade non-Hodgkin lymphomaBradley J G Larson, John M Waples, Annette Pusateri, et al.
Pageof 2